Effects of the cholinergic channel activator ABT-418 on cortical EEG: Comparison with (-)-nicotine

Drug Development Research

Volumn 37, Issue 2, 1996, Pages 73-74

  Radek, Richard J ^a   Briggs, Clark A ^a   Sullivan, James P ^a   Kang, Chae Hee ^a   Arneric, Stephen P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

( ) Nicotine; ABT 418; EEG; HVS; Mecamylamine; Sleep; Spike and wave

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; CHOLINERGIC RECEPTOR STIMULATING AGENT; MECAMYLAMINE; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

EID: 0030003838     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199602)37:2<73::AID-DDR2>3.0.CO;2-I     Document Type: Article

References (26)

1. Aldinio C, Aporti F, Calderini G, Mazzari S, Zanotti A, Toffano G (1985): Experimental models of aging and quinolinic acid. Methods Find Exp Clin Pharmacol 7:563-568.
2. Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raskiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS, Wasicak J, Williams M (1994): (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J Pharmacol Exp Ther 270:310-318.
3. Arneric SP, Sullivan JP, Decker MW, Brioni JD, Bannon AW, Briggs CA, Donnelly-Roberts D, Radek RJ, Marsh KC, Kyncl J, Williams M, Buccafusco JJ (1995): Potential treatment of Alzheimer's disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like and cytoprotective properties. Alzheimer Dis Assoc Disord 9:(2):50-61.
4. Benowitz NL (1991): Nicotine and coronary heart disease. Trends Cardiovasc Med 1:315-321.
5. Brioni JD, O'Neill AB, Kim JB, Decker MW (1993): Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus maze. Eur J Pharmacol 238:1-8.
6. Brioni JD, O'Neill AB, Kim JB, Buckley MJ, Decker MW, Arneric SP (1994): Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J Pharmacol Exp Ther 271:353-361.
7. Coenen AM, Drinkenburg WH, Peeters BW, Vossen JM, Van Luijtelaar EL (1991): Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain. Neurosci Biobehav Rev 15:259-263.
8. Danober L, Depaulis A, Marescaux C, Vergnes M (1993): Effects of cholinergic drugs on genetic absence seizures in rats. Eur J Pharmacol 234:263-268.
9. Decker MW, Majchrzak MJ, Anderson DJ (1992): Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res 572:281-285.
10. Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJB, Giardina WJ, Williams M, Arneric SP (1994a): (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. J Pharmacol Exp Ther 270:319-328.
11. Decker MW, Curzon P, Brioni JD, Americ SP (1994b): Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur J Pharmacol 261:217-222.
12. Garvey DS, Wasicak JT, Decker MW, Brioni JD, Buckley MJ, Sullivan JP, Carrera GM, Holladay MW, Arneric SP, Williams M (1994): Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities. J Med Chem 37:1055-1059.
13. Gillin JC, Lardon M, Ruiz C, Golshan S, Salin-Pascual R (1994): Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers. J Clin Psychopharmacol 14:264-267.
14. Lugaresi E (1992): The thalamus and insomnia. Neurology 42:28-33.
15. McGehee DS, Role LW (1995): Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546.
16. Plum P (1991): Coma and related global disturbances of the human conscious state. In Peters A, Jones EJ (eds): Cerebral Cortex, vol. 9. New York: Plenum, pp. 359-425.
17. Radek RJ (1993): Effects of nicotine on cortical high voltage spindles in rats. Brain Res 625:23-28.
18. Radek RJ, Briggs C, Sullivan J, Kang CH, Arneric SP (1993): Effects of subchronic nicotine on rat EEG. Soc Neurosci Abstr 19:913 (Abstract).
19. Radek RJ, Curzon P, Decker MW (1994): Characterization of high voltage spindles and spatial memory in young, mature and aged rats. Brain Res Bull 33:183-188.
20. Ryan LJ (1985): Neural mechanisms distinguishing the neocortical EEG of C57BL/6 mice from that of DBA/2 mice. Brain Res Bull 14:205-209.
21. Snead OC (1995): Basic mechanisms of generalized absence seizures. Ann Neurol 37:146-157.
22. Soldatos CR, Kales JD, Scharf MB, Bixler EO, Kales A (1980): Cigarette smoking associated with sleep difficulty. Science 207: 551-553.
23. Steriade M, Contreras D, Amzica F (1994): Synchronized sleep oscillations and their paroxysmal developments. Trends Neurosci 17:199-208.
24. Stolerman IP, Mirza NR. Shoaib M (1995): Nicotine psychopharmacology: Addiction, cognition and neuroadaptation. Med Res Rev 15:47-72.
25. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, Mcfalls E, Kovera C, Mccarten JR (1995): Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514.
26. Yamamoto KI, Domino EF (1965): Nicotine-induced EEC and behavioral arousal. Int J Neuropharmacol 4:359-373.